Back    Zoom +    Zoom -
<Research>G Sachs Ratings, TPs for CN Healthcare Sector (Table)
Recommend
41
Positive
40
Negative
51
Stock | Rating | Target Price (HKD)

PHARMARON (03759.HK) | Buy | 31
WUXI XDC (02268.HK) | Buy | 85.9
EDGE MEDICAL-B (02675.HK) | Buy | 81
TIGERMED (03347.HK) | Buy | 61.4
MEDBOT-B (02252.HK) | Buy | 45

Related NewsUBS: WUXI APPTEC (02359.HK) Zero-Coupon Convertible Bond Issuance Slightly Positive, Reflects Management Confidence
ASYMCHEM (06821.HK) | Buy | 118.7
GUSHENGTANG (02273.HK) | Buy | 35.4 → 35.2
WUXI APPTEC (02359.HK) | Conviction List Buy | 149.7
AK MEDICAL (01789.HK) | Neutral → Buy | 7.1 → 8.4
GENSCRIPT BIO (01548.HK) | Buy | 17.14

ANGELALIGN (06699.HK) | Buy | 100 → 110
HYGEIA HEALTH (06078.HK) | Neutral | 14.3
WUXI BIO (02269.HK) | Neutral | 41
WEIGAO GROUP (01066.HK) | Buy → Neutral | 6 → 4
MICROTECH MED-B (02235.HK) | Sell → Neutral | 8.2 → 8.9

SINOPHARM (01099.HK) | Neutral | 19.83
CHINARES PHARMA (03320.HK) | Neutral | 6.03
FRONTAGE (01521.HK) | Sell | 1.01
JXR (01951.HK) | Sell | 2.29 → 2.4
SH PHARMA (02607.HK) | Sell | 10.3

Related NewsCiti: TIGERMED CONSULTING Fundamentals Unaffected; Share Price Weakness Seen as Entry Pt

Auto-translated by AI
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details

AASTOCKS Financial News